AI Bias Analysis
4 models · Takes ~15 seconds
(MedPage Today) -- A "top-down" approach of early aggressive therapy for Crohn's disease continued to achieve better outcomes versus a conventional accelerated "step-up" approach, long-term follow-up data from the PROFILE trial showed. At 5-year...
Source
MedPage Today
Opens original article in a new tab
(MedPage Today) -- When your patients turn 65, will they automatically be enrolled in a Medicare Advantage plan or accountable care organization (ACO)? That idea is now on the Trump administration's radar. CMS is currently mulling a plan that...
Here are key takeaways from a WHO briefing on the hantavirus outbreak aboard a cruise ship.
(MedPage Today) -- The Trump administration will soon propose softening Biden-era limits on "forever chemicals" in drinking water, delaying but keeping tough standards for two common types and rescinding limits on some rarer forms of the substance...
(MedPage Today) -- DENVER -- Men using phosphodiesterase type 5 (PDE-5) inhibitors for erectile dysfunction (ED) had a modestly lower risk of glaucoma, according to a study reported here. During 3 years of follow-up, men taking PDE-5 inhibitors...
